Literature DB >> 6337081

Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?

R Pérez Tamayo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337081     DOI: 10.1002/hep.1840030118

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  67 in total

1.  Effect of dietary nucleotides on degree of fibrosis and steatosis induced by oral intake of thioacetamide.

Authors:  M I Torres; M I Fernandez; A Gil; A Rios
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.

Authors:  G Abdel-Aziz; G Lebeau; P Y Rescan; B Clément; M Rissel; Y Deugnier; J P Campion; A Guillouzo
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CCl4 rat model.

Authors:  B H Davis; J A Madri
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

4.  A new rat model of portal hypertension induced by intraportal injection of microspheres.

Authors:  Xiang-Nong Li; IS Benjamin; B Alexander
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

5.  Prolonged reduction of hepatocyte proliferative ability in rats after a single treatment with carbon tetrachloride.

Authors:  J Kanta; E Kvasnicková; F Bartos
Journal:  Int J Exp Pathol       Date:  1992-02       Impact factor: 1.925

6.  Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model.

Authors:  Norihiro Imai; Michitaka Suzuki; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Kazuhiko Hayashi; Masatoshi Ishigami; Yoshiki Hirooka; Tetsuya Ishikawa; Hidemi Goto; Toyoshi Fujimoto
Journal:  Histochem Cell Biol       Date:  2017-04-18       Impact factor: 4.304

7.  Hepatoprotection by malotilate against carbon tetrachloride-alcohol-induced liver fibrosis.

Authors:  C P Siegers; V Pauli; G Korb; M Younes
Journal:  Agents Actions       Date:  1986-08

8.  Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.

Authors:  Da-Hee Jeong; Gi-Ppeum Lee; Won-Il Jeong; Sun-Hee Do; Hai-Jie Yang; Dong-Wei Yuan; Ho-Yong Park; Kyu-Jong Kim; Kyu-Shik Jeong
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

9.  Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis.

Authors:  S Mitsue; M Hamanoue; G Tanabe; Y Ogura; S Yoshidome; T Aikou; T Nakamura
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  Combinatorial gene therapy renders increased survival in cirrhotic rats.

Authors:  Francisco J Gálvez-Gastélum; Aida A Segura-Flores; María D Senties-Gomez; Jose F Muñoz-Valle; Juan S Armendáriz-Borunda
Journal:  J Biomed Sci       Date:  2010-05-28       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.